Citadel Advisors »

SAB Biotherapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of SAB Biotherapeutics shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in SAB Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including SAB Biotherapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SAB Biotherapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $12k 17k 0.69
2023-03-31 $13k 28k 0.44
2022-12-31 $64k 109k 0.59
2021-12-31 $188k 24k 7.77

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding SAB Biotherapeutics

BVF
Sessa Capital IM
Pathstone Holdings
Kestra Advisory Services
Mariner Wealth Advisors
Creative Planning
Citadel Advisors
Baird Financial
LM Advisors
UBS Group
Royal Bank of Canada
Bank of America Corporation

View all funds holding SAB Biotherapeutics